We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CURR market cap is 8.05M. The company's latest EPS is USD -0.0470 and P/E is -2.34.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 623k | 2.05M | 6.56M | 5.47M | 4.85M |
| Operating Income | -13.69M | -18.96M | -16.87M | -18.27M | -5.51M |
| Net Income | -21.36M | -30.62M | -13.19M | -18.54M | -3.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.46M | 46.36M | 40.57M | 6.85M | 2.61M |
| Total Liabilities | 18.95M | 25.08M | 24.46M | 13.96M | 12.49M |
| Total Equity | 13.51M | 21.28M | 16.11M | -7.11M | -9.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.1M | -9.72M | -4.32M | -10.07M | -3.84M |
| Investing | 7.57M | -131k | -175k | 13.84M | 971k |
| Financing | 4.13M | 7.48M | 2.78M | -837k | -22k |
| Market Cap | 8.05M |
| Price to Earnings Ratio | -2.34 |
| Price to Sales Ratio | 1.66 |
| Price to Cash Ratio | 157.14 |
| Price to Book Ratio | -0.81 |
| Dividend Yield | - |
| Shares Outstanding | 73.2M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -2.96% |
| 52 Week High | 0.135 |
| 52 Week Low | 0.03 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Cure Pharmaceutical Holding Corporation (PK) |
| Address |
701 s carson st ste 200 carson city, nevada 89701 |
| Website | https://www.avenirwellness.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
